Skip to main content
Erschienen in: Rheumatology International 6/2007

01.04.2007 | Original Article

Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study

verfasst von: Reto Widrig, Andy Suter, Reinhard Saller, Jörg Melzer

Erschienen in: Rheumatology International | Ausgabe 6/2007

Einloggen, um Zugang zu erhalten

Abstract

The use of topical preparations for symptom relief is common in osteoarthritis. The effects of ibuprofen (5%) and arnica (50 g tincture/100 g, DER 1:20), as gel preparations in patients with radiologically confirmed and symptomatically active osteoarthritis of interphalangeal joints of hands, were evaluated in a randomised, double-blind study in 204 patients, to ascertain differences in pain relief and hand function after 21 days’ treatment. Diagnosis was according to established criteria; primary endpoints were pain intensity and hand function; statistical design was as per current regulatory guidelines for testing topical preparations. There were no differences between the two groups in pain and hand function improvements, or in any secondary end points evaluated. Adverse events were reported by six patients (6.1%) on ibuprofen and by five patients (4.8%) on arnica. Our results confirm that this preparation of arnica is not inferior to ibuprofen when treating osteoarthritis of hands.
Literatur
1.
Zurück zum Zitat Zhang Y, Niu J, Kelly-Hayes M et al (2002) Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Am J Epidemiol 156:1021–1027PubMedCrossRef Zhang Y, Niu J, Kelly-Hayes M et al (2002) Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: the Framingham Study. Am J Epidemiol 156:1021–1027PubMedCrossRef
2.
Zurück zum Zitat Hochberg MC, Vignon E, Maheu E (2000) Clinical assessment of hand OA. Osteoarthr Cartil 8(Suppl A):S38–S40PubMed Hochberg MC, Vignon E, Maheu E (2000) Clinical assessment of hand OA. Osteoarthr Cartil 8(Suppl A):S38–S40PubMed
3.
Zurück zum Zitat Stamm TA, Machold KP, Smolen JS et al (2002) Joint protection and home hand exercises improve hand function in patients with hand osteoarthritis: a randomized controlled trial. Arthritis Rheum 47:44–49PubMedCrossRef Stamm TA, Machold KP, Smolen JS et al (2002) Joint protection and home hand exercises improve hand function in patients with hand osteoarthritis: a randomized controlled trial. Arthritis Rheum 47:44–49PubMedCrossRef
4.
Zurück zum Zitat Moore N (2003) Forty years of ibuprofen use. Int J Clin Pract 135(Suppl Apr):28–31 Moore N (2003) Forty years of ibuprofen use. Int J Clin Pract 135(Suppl Apr):28–31
5.
Zurück zum Zitat Heyneman CA, Lawless-Liday C, Wall GC (2000) Oral versus topical NSAIDs in rheumatic diseases. Drugs 60:555–574PubMedCrossRef Heyneman CA, Lawless-Liday C, Wall GC (2000) Oral versus topical NSAIDs in rheumatic diseases. Drugs 60:555–574PubMedCrossRef
6.
Zurück zum Zitat Moore RA, Tramèr MR, Carroll D et al (1998) Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333–338PubMed Moore RA, Tramèr MR, Carroll D et al (1998) Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ 316:333–338PubMed
7.
Zurück zum Zitat Ramesh N, Steuber U (1983) Dolgit® cream in accident- and sports-related injuries in medical practice. Results of a double blind study. Therapiewoche 33:4563–4570 Ramesh N, Steuber U (1983) Dolgit® cream in accident- and sports-related injuries in medical practice. Results of a double blind study. Therapiewoche 33:4563–4570
8.
Zurück zum Zitat Machen J, Whitefield M (2002) Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double-blind, placebo-controlled study. Int J Clin Pract 56:102–106PubMed Machen J, Whitefield M (2002) Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomised, double-blind, placebo-controlled study. Int J Clin Pract 56:102–106PubMed
9.
Zurück zum Zitat Dreiser RL (1988) Clinical trial of efficacy and tolerability of topical ibuprofen in the treatment of tendonitis. Le J Int Méd 119:15–31 Dreiser RL (1988) Clinical trial of efficacy and tolerability of topical ibuprofen in the treatment of tendonitis. Le J Int Méd 119:15–31
10.
Zurück zum Zitat Nasonova VA Muravyev IuV, Nasonov EL et al (1995) Local application of dolgit cream in patients with osteoarthritis: multicentre study of efficacy and tolerance. Ter Arkh 67:48–50 Nasonova VA Muravyev IuV, Nasonov EL et al (1995) Local application of dolgit cream in patients with osteoarthritis: multicentre study of efficacy and tolerance. Ter Arkh 67:48–50
11.
Zurück zum Zitat Guillaume M (1988) Clinical study on the efficacy and tolerability of percutaneous ibuprofen for the symptomatic treatment of arthrosis of small joints. Etude clinique de l’efficacité et de la tolérance de l’ibuprofène percutané dans le traitement symptomatique de l’arthrose des petites articulations. J Intern Med 2:1–4 Guillaume M (1988) Clinical study on the efficacy and tolerability of percutaneous ibuprofen for the symptomatic treatment of arthrosis of small joints. Etude clinique de l’efficacité et de la tolérance de l’ibuprofène percutané dans le traitement symptomatique de l’arthrose des petites articulations. J Intern Med 2:1–4
12.
Zurück zum Zitat Trnavsky K, Fischer M, Voegtle-Junkert U, Schreyger F (2004) Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. J Rheumatol 31:565–572PubMed Trnavsky K, Fischer M, Voegtle-Junkert U, Schreyger F (2004) Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. J Rheumatol 31:565–572PubMed
13.
Zurück zum Zitat Dominkus M, Nicolakis M, Kotz R et al (1996) Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung 46:1138–1143PubMed Dominkus M, Nicolakis M, Kotz R et al (1996) Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung 46:1138–1143PubMed
14.
Zurück zum Zitat Steen AE, Reeh PW, Geisslinger G et al (2004) Plasma levels after peroral and topical ibuprofen and effects upon low pH induced cutaneous and muscle pain. Eur J Pain 4:195–209CrossRef Steen AE, Reeh PW, Geisslinger G et al (2004) Plasma levels after peroral and topical ibuprofen and effects upon low pH induced cutaneous and muscle pain. Eur J Pain 4:195–209CrossRef
15.
Zurück zum Zitat Ernst E (2004) Musculoskeletal conditions and complementary/alternative medicine. Best Pract Res Clin Rheumatol 18:539–556PubMedCrossRef Ernst E (2004) Musculoskeletal conditions and complementary/alternative medicine. Best Pract Res Clin Rheumatol 18:539–556PubMedCrossRef
16.
Zurück zum Zitat Mayer JG et al (2000) Arnica montana or Mountain Arnica—a cultural–historical essay and on the problems of writing such an essay. Arnica montana L., oder Bergwohlverleih – Ein kulturhistorischer Essay – und über die Schwierigkeiten einen solchen zu verfassen. Zeitschrift für Phytotherapie 21:30–36 Mayer JG et al (2000) Arnica montana or Mountain Arnica—a cultural–historical essay and on the problems of writing such an essay. Arnica montana L., oder Bergwohlverleih – Ein kulturhistorischer Essay – und über die Schwierigkeiten einen solchen zu verfassen. Zeitschrift für Phytotherapie 21:30–36
17.
Zurück zum Zitat Knuesel O, Weber M, Suter A (2002) Arnica montana gel in osteoarthritis of the knee: an open, multicentre clinical trial. Adv Ther 19:209–218PubMed Knuesel O, Weber M, Suter A (2002) Arnica montana gel in osteoarthritis of the knee: an open, multicentre clinical trial. Adv Ther 19:209–218PubMed
18.
Zurück zum Zitat Lyss G, Schmidt TJ, Merfort I et al (1997) Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-KappaB. Biol Chem 378:951–961PubMedCrossRef Lyss G, Schmidt TJ, Merfort I et al (1997) Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-KappaB. Biol Chem 378:951–961PubMedCrossRef
19.
Zurück zum Zitat De Bosscher K, Vanden Berghe W, Vermeulen L et al (2000) Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Nat Acad Sci 97:3919–3924PubMedCrossRef De Bosscher K, Vanden Berghe W, Vermeulen L et al (2000) Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Nat Acad Sci 97:3919–3924PubMedCrossRef
20.
Zurück zum Zitat Wagner S, Suter A, Merfort I (2004) Skin penetration studies of Arnica preparations and of their sesquiterpene lactones. Planta Med 70:897–903PubMedCrossRef Wagner S, Suter A, Merfort I (2004) Skin penetration studies of Arnica preparations and of their sesquiterpene lactones. Planta Med 70:897–903PubMedCrossRef
21.
Zurück zum Zitat Altman R, Alarcon G, Appelrouth D et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610PubMedCrossRef Altman R, Alarcon G, Appelrouth D et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610PubMedCrossRef
22.
Zurück zum Zitat Lequesne MG, Maheu E (2000) Methodology of clinical trials in hand osteoarthritis: conventional and proposed tools. Osteoarthr Cartil 8(Suppl A):S64–S69PubMed Lequesne MG, Maheu E (2000) Methodology of clinical trials in hand osteoarthritis: conventional and proposed tools. Osteoarthr Cartil 8(Suppl A):S64–S69PubMed
25.
Zurück zum Zitat Dreiser RL, Maheu E, Guillou GB et al (1995) Validation of an algofunctional index for osteoarthritis of the hand. Rev Rhum Engl Ed 62(6 Suppl 1):S43–S53 Dreiser RL, Maheu E, Guillou GB et al (1995) Validation of an algofunctional index for osteoarthritis of the hand. Rev Rhum Engl Ed 62(6 Suppl 1):S43–S53
26.
Zurück zum Zitat Vaile J, Davis P (1998) Topical NSAIDs for musculoskeletal conditions. A review of the literature. Drugs 56:783–799PubMedCrossRef Vaile J, Davis P (1998) Topical NSAIDs for musculoskeletal conditions. A review of the literature. Drugs 56:783–799PubMedCrossRef
27.
Zurück zum Zitat Lin J, Zhand W, Jones A, Doherty M (2004) Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329(7461):324PubMedCrossRef Lin J, Zhand W, Jones A, Doherty M (2004) Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 329(7461):324PubMedCrossRef
29.
Zurück zum Zitat Whitefield M, O’Kane CJA (2002) Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther 27:409–417PubMedCrossRef Whitefield M, O’Kane CJA (2002) Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther 27:409–417PubMedCrossRef
Metadaten
Titel
Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study
verfasst von
Reto Widrig
Andy Suter
Reinhard Saller
Jörg Melzer
Publikationsdatum
01.04.2007
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 6/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-007-0304-y

Weitere Artikel der Ausgabe 6/2007

Rheumatology International 6/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.